221 related articles for article (PubMed ID: 24055197)
1. Galactosylation of IgG1 modulates FcγRIIB-mediated inhibition of murine autoimmune hemolytic anemia.
Yamada K; Ito K; Furukawa J; Nakata J; Alvarez M; Verbeek JS; Shinohara Y; Izui S
J Autoimmun; 2013 Dec; 47():104-10. PubMed ID: 24055197
[TBL] [Abstract][Full Text] [Related]
2. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice.
Baudino L; Nimmerjahn F; Azeredo da Silveira S; Martinez-Soria E; Saito T; Carroll M; Ravetch JV; Verbeek JS; Izui S
J Immunol; 2008 Feb; 180(3):1948-53. PubMed ID: 18209093
[TBL] [Abstract][Full Text] [Related]
3. Lack of galactosylation enhances the pathogenic activity of IgG1 but Not IgG2a anti-erythrocyte autoantibodies.
Ito K; Furukawa J; Yamada K; Tran NL; Shinohara Y; Izui S
J Immunol; 2014 Jan; 192(2):581-8. PubMed ID: 24337750
[TBL] [Abstract][Full Text] [Related]
4. FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia.
Meyer D; Schiller C; Westermann J; Izui S; Hazenbos WL; Verbeek JS; Schmidt RE; Gessner JE
Blood; 1998 Dec; 92(11):3997-4002. PubMed ID: 9834201
[TBL] [Abstract][Full Text] [Related]
5. Impact of a three amino acid deletion in the CH2 domain of murine IgG1 on Fc-associated effector functions.
Baudino L; Nimmerjahn F; Shinohara Y; Furukawa J; Petry F; Verbeek JS; Nishimura S; Ravetch JV; Izui S
J Immunol; 2008 Sep; 181(6):4107-12. PubMed ID: 18768867
[TBL] [Abstract][Full Text] [Related]
6. Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis.
Schiller C; Janssen-Graalfs I; Baumann U; Schwerter-Strumpf K; Izui S; Takai T; Schmidt RE; Gessner JE
Eur J Immunol; 2000 Feb; 30(2):481-90. PubMed ID: 10671203
[TBL] [Abstract][Full Text] [Related]
7. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
8. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
[TBL] [Abstract][Full Text] [Related]
9. Anti-FcγRIIB mAb suppresses murine IgG-dependent anaphylaxis by Fc domain targeting of FcγRIII.
Clay CD; Strait RT; Mahler A; Khodoun MV; Finkelman FD
J Allergy Clin Immunol; 2018 Apr; 141(4):1373-1381.e5. PubMed ID: 28624610
[TBL] [Abstract][Full Text] [Related]
10. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.
Fossati-Jimack L; Ioan-Facsinay A; Reininger L; Chicheportiche Y; Watanabe N; Saito T; Hofhuis FM; Gessner JE; Schiller C; Schmidt RE; Honjo T; Verbeek JS; Izui S
J Exp Med; 2000 Apr; 191(8):1293-302. PubMed ID: 10770797
[TBL] [Abstract][Full Text] [Related]
11. Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Clay CD; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Dec; 132(6):1375-87. PubMed ID: 24139828
[TBL] [Abstract][Full Text] [Related]
12. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB.
Nandakumar KS; Andrén M; Martinsson P; Bajtner E; Hellström S; Holmdahl R; Kleinau S
Eur J Immunol; 2003 Aug; 33(8):2269-77. PubMed ID: 12884302
[TBL] [Abstract][Full Text] [Related]
13. IgG subclasses determine pathways of anaphylaxis in mice.
Beutier H; Gillis CM; Iannascoli B; Godon O; England P; Sibilano R; Reber LL; Galli SJ; Cragg MS; Van Rooijen N; Mancardi DA; Bruhns P; Jönsson F
J Allergy Clin Immunol; 2017 Jan; 139(1):269-280.e7. PubMed ID: 27246523
[TBL] [Abstract][Full Text] [Related]
14. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.
Sonneveld ME; de Haas M; Koeleman C; de Haan N; Zeerleder SS; Ligthart PC; Wuhrer M; van der Schoot CE; Vidarsson G
Sci Rep; 2017 Aug; 7(1):8187. PubMed ID: 28811589
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.
Karsten CM; Pandey MK; Figge J; Kilchenstein R; Taylor PR; Rosas M; McDonald JU; Orr SJ; Berger M; Petzold D; Blanchard V; Winkler A; Hess C; Reid DM; Majoul IV; Strait RT; Harris NL; Köhl G; Wex E; Ludwig R; Zillikens D; Nimmerjahn F; Finkelman FD; Brown GD; Ehlers M; Köhl J
Nat Med; 2012 Sep; 18(9):1401-6. PubMed ID: 22922409
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms.
Shibata T; Berney T; Reininger L; Chicheportiche Y; Ozaki S; Shirai T; Izui S
Int Immunol; 1990; 2(12):1133-41. PubMed ID: 2090198
[TBL] [Abstract][Full Text] [Related]
17. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometry analysis of IGG subclasses of auto- and alloantibodies in autoimmune hemolytic anemia and hemolytic disease of the newborn].
Lynen R; Neuhaus R; Simson G; Riggert J; Köhler M
Beitr Infusionsther Transfusionsmed; 1994; 32():203-7. PubMed ID: 9480088
[TBL] [Abstract][Full Text] [Related]
19. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
[TBL] [Abstract][Full Text] [Related]
20. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
Kumar V; Ali SR; Konrad S; Zwirner J; Verbeek JS; Schmidt RE; Gessner JE
J Clin Invest; 2006 Feb; 116(2):512-20. PubMed ID: 16453025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
